Nordson Operating Cash Flow increased by 28.7% to $180.67M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 51.6%, from $119.17M to $180.67M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 7.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $104.43M | $127.74M | $170.47M | $118.09M | $96.41M | $125.19M | $173.44M | $123.34M | $164.57M | $190.17M | $163.21M | $172.36M | $122.61M | $164.85M | $96.38M | $159.12M | $119.17M | $237.97M | $202.91M | $140.43M | $180.67M |
| QoQ Change | — | +22.3% | +33.4% | -30.7% | -18.4% | +29.8% | +38.5% | -28.9% | +33.4% | +15.6% | -14.2% | +5.6% | -28.9% | +34.5% | -41.5% | +65.1% | -25.1% | +99.7% | -14.7% | -30.8% | +28.7% |
| YoY Change | — | — | — | — | -7.7% | -2.0% | +1.7% | +4.4% | +70.7% | +51.9% | -5.9% | +39.7% | -25.5% | -13.3% | -40.9% | -7.7% | -2.8% | +44.4% | +110.5% | -11.7% | +51.6% |